← FDA Drug Approvals (Drugs@FDA)

EPINEPHRINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2024-11-20

Drug application

FDA Application #

ANDA213708

Application type

Abbreviated New Drug Application (Generic)

Brand name

EPINEPHRINE

Generic name

EPINEPHRINE

Active ingredients

EPINEPHRINE

Dosage form

SOLUTION

Route

INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS

Marketing status

Prescription

Sponsor

FRESENIUS KABI USA

Manufacturer

Fresenius Kabi USA, LLC

First approval

2024-11-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown